Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Current practice and short-term outcomes of therapeutic mammaplasty in the international TeaM multicentre prospective cohort study.

O'Connell RL, Baker E, Trickey A, Rattay T, Whisker L, Macmillan RD, Potter S; TeaM Steering Group; Mammary Fold Academic and Research Collaborative.

Br J Surg. 2018 Dec;105(13):1778-1792. doi: 10.1002/bjs.10959. Epub 2018 Aug 22.

PMID:
30132807
2.

Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long-term effects based on sequential biopsies.

Agrawal A, Robertson JF, Cheung KL, Gutteridge E, Ellis IO, Nicholson RI, Gee JM.

Int J Cancer. 2016 Jan 1;138(1):146-59. doi: 10.1002/ijc.29682. Epub 2015 Jul 30.

3.

Pilot randomised study of early intervention based on tumour markers in the follow-up of patients with primary breast cancer.

Mathew J, Prinsloo P, Agrawal A, Gutteridge E, Marenah C, Robertson JF, Cheung KL.

Breast. 2014 Oct;23(5):567-72. doi: 10.1016/j.breast.2014.04.003. Epub 2014 May 27.

PMID:
24874285
4.

Surgical and oncological outcome after skin-sparing mastectomy and immediate breast reconstruction.

Agrawal A, Grewal M, Sibbering DM, Courtney CA.

Clin Breast Cancer. 2013 Dec;13(6):478-81. doi: 10.1016/j.clbc.2013.08.013. Epub 2013 Oct 8.

PMID:
24119787
5.

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, Dobbs HJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Simmons S, Sydenham MA, Venables K, Bliss JM, Yarnold JR; START Trialists' Group.

Lancet Oncol. 2013 Oct;14(11):1086-1094. doi: 10.1016/S1470-2045(13)70386-3. Epub 2013 Sep 19.

PMID:
24055415
6.

Skin sparing mastectomy and immediate breast reconstruction: a review.

Agrawal A, Sibbering DM, Courtney CA.

Eur J Surg Oncol. 2013 Apr;39(4):320-8. doi: 10.1016/j.ejso.2012.12.015. Epub 2013 Jan 17. Review.

PMID:
23333068
7.

Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancer.

Agrawal A, Robertson JF, Cheung KL.

World J Surg Oncol. 2011 Sep 9;9:101. doi: 10.1186/1477-7819-9-101.

8.

Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal women.

Cheung KL, Agrawal A, Folkerd E, Dowsett M, Robertson JF, Winterbottom L.

Eur J Cancer. 2010 Nov;46(16):2936-42. doi: 10.1016/j.ejca.2010.08.005. Epub 2010 Sep 9.

PMID:
20832294
9.

Adenosquamous carcinoma of breast in a 19 years old woman: a case report.

Agrawal A, Saha S, Ellis IO, Bello AM.

World J Surg Oncol. 2010 May 27;8:44. doi: 10.1186/1477-7819-8-44.

10.

The effects of gefitinib in tamoxifen-resistant and hormone-insensitive breast cancer: a phase II study.

Gutteridge E, Agrawal A, Nicholson R, Cheung KL, Robertson J, Gee J.

Int J Cancer. 2010 Apr 15;126(8):1806-1816. doi: 10.1002/ijc.24884.

11.

Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy.

Okunade G, Green AR, Ying M, Agrawal A, Paish EC, Aleskandrany M, Winterbottom L, Hassell K, Morgan DA, Ellis IO, Cheung KL.

Crit Rev Oncol Hematol. 2009 Oct;72(1):76-82. doi: 10.1016/j.critrevonc.2009.01.005. Epub 2009 Jun 9.

PMID:
19515574
12.

Bone turnover markers in postmenopausal breast cancer treated with fulvestrant--a pilot study.

Agrawal A, Hannon RA, Cheung KL, Eastell R, Robertson JF.

Breast. 2009 Jun;18(3):204-7. doi: 10.1016/j.breast.2009.04.002. Epub 2009 May 21.

PMID:
19464177
13.

Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.

Mathew J, Agrawal A, Asgeirsson KS, Buhari SA, Jackson LR, Cheung KL, Robertson JF.

Breast Cancer Res Treat. 2009 Jan;113(2):403-7. doi: 10.1007/s10549-008-9930-7. Epub 2008 Mar 2.

PMID:
18311583
14.

Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients.

Asgeirsson KS, Agrawal A, Allen C, Hitch A, Ellis IO, Chapman C, Cheung KL, Robertson JF.

Breast Cancer Res. 2007;9(6):R75.

15.

Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? A prospective study.

Bristow AR, Agrawal A, Evans AJ, Burrell HC, Cornford EJ, James JJ, Hamilton L, Robertson JF, Chan SY, Lawton PA, Cheung KL.

Breast. 2008 Feb;17(1):98-103. Epub 2007 Sep 24.

PMID:
17890090
16.

Esophagogastric cancers secondary to a breast primary tumor do not require resection.

Ayantunde AA, Agrawal A, Parsons SL, Welch NT.

World J Surg. 2007 Aug;31(8):1597-601. Review.

PMID:
17578645
17.

Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experience.

Mathew J, Asgeirsson KS, Agrawal A, Mukherjee A, Ellis IO, Cheung KL, Chan SY, Robertson JF.

Eur J Surg Oncol. 2007 Oct;33(8):972-6. Epub 2007 Mar 27.

PMID:
17391905
18.

Concepts of seroma formation and prevention in breast cancer surgery.

Agrawal A, Ayantunde AA, Cheung KL.

ANZ J Surg. 2006 Dec;76(12):1088-95. Review.

PMID:
17199696
19.

Male breast cancer: a review of clinical management.

Agrawal A, Ayantunde AA, Rampaul R, Robertson JF.

Breast Cancer Res Treat. 2007 May;103(1):11-21. Epub 2006 Oct 11. Review.

PMID:
17033919

Supplemental Content

Loading ...
Support Center